Author: "Glaspy J" / Database: Journals@OVID - Searchworks@Jio Institute Digital Library Search Results

Searchworks

Select search scope, currently: Articles

Catalog

books, media & more in Jio Institute collections

Articles

journal articles & other e-resources

Your search keyword '"Glaspy J"' showing total 6 results

Start Over Author "Glaspy J" Database Journals@OVID

6 results on '"Glaspy J"'

1. Control of cancer-related anemia with erythropoietic agents: a review of evidence for improved quality of life and clinical outcomes

Author: Cella, D., Dobrez, D., and Glaspy, J.
Published: 2003

2. Darbepoetin alfa is effective in patients with chronic anemia of cancer when administered weekly (QW), every 3 weeks (Q3W), or every 4 weeks (Q4W)

Author: Smith, R, Tchekmedyian, S, Richards, D, Klamet, J, Fleishman, A, Colowick, A, and Glaspy, J
Published: 2002

3. Loading/maintenance regimen of darbepoetin alfa achieves rapid and sustained hemoglobin (Hb) response and improved health-related quality of life (HRQOL) compared to rHuEPO

Author: Glaspy, J, Justice, G, Tchekmedyian, S, Jadeja, J, Kallich, J, Rossi, G, and Colowick, A
Published: 2002

4. Comparable efficacy and safety profiles of once-per-cycle pegfilgrastim and daily injection filgrastim in chemotherapy-induced neutropenia: a multicenter dose-finding study in women with breast cancer

Author: Holmes, F. A., Jones, S. E., O'Shaughnessy, J., Vukelja, S., George, T., Savin, M., Richards, D., Glaspy, J., Meza, L., Cohen, G., Dhami, M., Budman, D. R., Hackett, J., Brassard, M., Yang, B. B., and Liang, B. C.
Published: 2002

5. Blinded, Randomized, Multicenter Study to Evaluate Single Administration Pegfilgrastim Once per Cycle Versus Daily Filgrastim as an Adjunct to Chemotherapy in Patients With High-Risk Stage II or Stage III/IV Breast Cancer

Author: Holmes, F.A., O’Shaughnessy, J.A., Vukelja, S., Jones, S.E., Shogan, J., Savin, M., Glaspy, J., Moore, M., Meza, L., Wiznitzer, I., Neumann, T.A., Hill, L.R., and Liang, B.C.
Published: 2002

6. PBPC MOBILIZATION: THE BENEFITS OF STEM CELL FACTOR (SCF, STEMGEN[registered sign]) AND AN OPTIMAL CD34+ CELL YIELD

Author: LeMaistre, C. F., Shpall, E. J., Turner, S. A., Wheeler, C. A., Yanovich, S., Brown, R. A., Pecora, A. L., Davis, M. W., Parker, W., and Glaspy, J. A.
Published: 1998

Catalog

Books, media, physical & digital resources

See catalog results